Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

GE HealthCare (GEHC) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareGEHC

Closing price · Nov 19, 2026 $81.77 -2.3% on the day · +13.2% over 12 months 52-week range $59.45 – $88.03
Get GEHC alerts
Open-market purchases8 insiders$6.4M · last 12 months
Insiders selling0last 12 months
Reported sales$0last 12 months
In 15 seconds

Insiders put their own money in: $6.4M of open-market buys. See how similar setups did below.

Past insider buys here: 8 of 8 beat the S&P 500 over the next 90 days. See each one ↓

Label: Strong buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Jan 21, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Purchase Kevin Lobo, Director bought 10,000 shares at $64.18 ($642K).

Trade date
May 22, 2026
Disclosed to the SEC
May 26, 2026
Type
Open-market purchase (code P)

Read the original SEC filing ↗All GEHC insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

GEHC insider transactions (Form 4)

Open-market purchases and sales. 70 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
May 26SEC Kevin LoboDirectorFirst buyStake +229% Buy 10,00014,363 held (+229%) $64.18 $642K +27.4% —
May 13SEC Rodney F. HochmanDirectorFirst buyNew position Buy 1,618new position $62.03 $100K +31.8% —
May 11SEC Watkin Phoebe L. YangDirectorFirst buy Buy 1,00013,702 held (+8%) $63.01 $63K +29.8% —
May 7SEC H. Lawrence Culp Jr.DirectorFirst buy in 3 yrsStake +115% Buy 80,805151,207 held (+115%) $61.88 $5.0M +32.1% —
May 7SEC William J. StrombergDirectorFirst buy Buy 1,00015,330 held (+7%) $61.69 $62K +32.6% —
May 1SEC James SaccaroCFOFirst buy Buy 3,31087,471 held (+4%) $60.60 $201K +34.9% —
Apr 30SEC Peter J. ArduiniCEO, PresidentFirst buy Buy 4,169259,424 held (+2%) $59.92 $250K +36.5% —
Apr 30SEC Frank R. JimenezGc & Corporate Secretary Buy 1,75093,932 held (+2%) $60.45 $106K +35.3% —
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for GEHC's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with GEHC in the Research Lab

Pre-set to GEHC's latest insider buy of $10K or more (May 26, 2026: Kevin Lobo, Rodney F. Hochman, $742K). Tap to change anything.

All tools →

Share price and insider trades

GEHC closeInsider buyInsider sale
5060708090DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-04EEarnings release filed 2026-04-29EEarnings release filed 2026-07-23EEarnings release filed 2026-07-29EEarnings release filed 2026-10-28Bought $63,006 on 2026-05-08 · Watkin Phoebe L. YangBought $100,365 on 2026-05-12 · Rodney F. HochmanBought $200,585 on 2026-05-01 · James SaccaroBought $355,615 on 2026-04-30 · Frank R. Jimenez, Peter J. ArduiniBought $641,800 on 2026-05-22 · Kevin LoboBought $5,061,765 on 2026-05-06 · H. Lawrence Culp Jr., William J. Stromberg
Bought, 12 months$6.4M
Sold, 12 months$0
Insiders buying8
Insiders selling0

GE HealthCare insider trading at a glance (Nov 20, 2026): in the past 12 months, 8 insiders bought $6.4M and 0 sold $0 of GEHC stock on the open market, including a cluster buy that began Apr 30, 2026; P/E 16.6 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

GEHC insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $6.4M bought (8 trades)$6.4MQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$6.4M8—0

Valuation, profit and volume

P/E (trailing)16.6Sector median 25.0
Volume vs. 50-day0.7×Last 5 sessions
Insiders' paper profit+$2.1MOn all tracked purchases +32.0%

Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 8 GE HealthCare insiders reported open-market purchases totaling $6.4M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Apr 30, 2026, when 7 insiders bought a combined $5.8M.

GEHC earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Oct 28, 2026 +5.0% None +7.5%S&P -0.0% pending
Jul 29, 2026 -1.8% None +9.1%S&P +0.1% +2.6%
Jul 23, 2026 -5.4% None -1.3%S&P -1.1% +23.5%
Apr 29, 2026 -7.2% None -11.2%S&P +1.0% +2.5%
Feb 4, 2026 -3.6% None +4.5%S&P -1.7% -9.8%
Oct 29, 2025 +10.6% None -5.5%S&P -1.1% +6.7%
Jul 30, 2025 +4.4% None -8.2%S&P -0.5% +3.4%
Apr 30, 2025 +5.8% None -0.6%S&P +0.7% +4.2%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

GEHC short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 66% of volume sold short2026-08-27: 63% of volume sold short2026-08-28: 63% of volume sold short2026-08-31: 65% of volume sold short2026-09-01: 64% of volume sold short2026-09-02: 41% of volume sold short2026-09-03: 67% of volume sold short2026-09-04: 77% of volume sold short2026-09-08: 56% of volume sold short2026-09-09: 55% of volume sold short2026-09-10: 59% of volume sold short2026-09-11: 47% of volume sold short2026-09-14: 46% of volume sold short2026-09-15: 69% of volume sold short2026-09-16: 67% of volume sold short2026-09-17: 66% of volume sold short2026-09-18: 79% of volume sold short2026-09-21: 70% of volume sold short2026-09-22: 60% of volume sold short2026-09-23: 72% of volume sold short2026-09-24: 74% of volume sold short2026-09-25: 40% of volume sold short2026-09-28: 56% of volume sold short2026-09-29: 60% of volume sold short2026-09-30: 64% of volume sold short2026-10-01: 56% of volume sold short2026-10-02: 53% of volume sold short2026-10-05: 62% of volume sold short2026-10-06: 50% of volume sold short2026-10-07: 52% of volume sold short2026-10-08: 68% of volume sold short2026-10-09: 60% of volume sold short2026-10-12: 64% of volume sold short2026-10-13: 73% of volume sold short2026-10-14: 71% of volume sold short2026-10-15: 56% of volume sold short2026-10-16: 56% of volume sold short2026-10-19: 42% of volume sold short2026-10-20: 60% of volume sold short2026-10-21: 65% of volume sold short2026-10-22: 58% of volume sold short2026-10-23: 57% of volume sold short2026-10-26: 48% of volume sold short2026-10-27: 50% of volume sold short2026-10-28: 42% of volume sold short2026-10-29: 49% of volume sold short2026-10-30: 52% of volume sold short2026-11-02: 39% of volume sold short2026-11-03: 25% of volume sold short2026-11-04: 41% of volume sold short2026-11-05: 53% of volume sold short2026-11-06: 55% of volume sold short2026-11-09: 44% of volume sold short2026-11-10: 56% of volume sold short2026-11-11: 49% of volume sold short2026-11-12: 59% of volume sold short2026-11-13: 71% of volume sold short2026-11-16: 67% of volume sold short2026-11-17: 54% of volume sold short2026-11-18: 55% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 55%20-day average: 48%Prior 2 months: 61%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded GEHC

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +18.2%

What happened after GEHC insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
May 26, 2026Kevin LoboDirector$642K -3.4%-4.6% vs S&P+1.2%+3.1% vs S&P+15.7%+13.7% vs S&P
May 13, 2026Rodney F. HochmanDirector$100K +3.8%+4.0% vs S&P+5.3%+5.4% vs S&P+17.6%+13.5% vs S&P
May 11, 2026Watkin Phoebe L. YangDirector$63K -0.3%-0.2% vs S&P+3.3%+5.2% vs S&P+18.3%+13.5% vs S&P
May 7, 2026H. Lawrence Culp Jr.Director$5.0M +2.2%-0.1% vs S&P+5.4%+4.4% vs S&P+14.6%+9.1% vs S&P
May 7, 2026William J. StrombergDirector$62K +2.2%-0.1% vs S&P+5.4%+4.4% vs S&P+14.6%+9.1% vs S&P
May 1, 2026James SaccaroCFO$201K +4.0%+1.6% vs S&P+2.7%-2.5% vs S&P+14.7%+11.5% vs S&P
Apr 30, 2026Peter J. ArduiniCEO, President$250K +0.8%-1.0% vs S&P+3.0%-2.5% vs S&P+18.2%+16.5% vs S&P
Apr 30, 2026Frank R. JimenezGc & Corporate Secretary$106K +0.8%-1.0% vs S&P+3.0%-2.5% vs S&P+18.2%+16.5% vs S&P

Insiders at GE HealthCare

InsiderBoughtSoldLast filingPast buys beat S&PScore
H. Lawrence Culp Jr.Director $5.0M — May 11, 2026 — —
Kevin LoboDirector $642K — May 26, 2026 — —
Peter J. ArduiniCEO, President $250K — Sep 4, 2026 — —
James SaccaroCFO $201K — May 1, 2026 — —
Frank R. JimenezGc & Corporate Secretary $106K — Sep 4, 2026 — —
Rodney F. HochmanDirector $100K — May 13, 2026 — —
Watkin Phoebe L. YangDirector $63K — May 11, 2026 — —
William J. StrombergDirector $62K — May 11, 2026 — —
Neal Joseph SandyCEO — — Nov 18, 2026 — —
William K. GroganCFO — — Sep 16, 2026 — —
Taha Kass-HoutCTO — — Sep 4, 2026 — —
Philip RackliffeCEO — — Sep 4, 2026 — —
Kevin Michael O'NeillCEO — — Sep 4, 2026 — —
Adam Y. HoltonChief People Officer — — Sep 4, 2026 — —
Catherine EstrampesChief Commer. & Growth Officer — — Sep 4, 2026 — —
George A. NewcombChief Accounting Officer — — Sep 4, 2026 — —
Jeannette BankesCEO — — Sep 3, 2026 — —
Catherine A. LesjakDirector — — May 11, 2026 — —
Anne T. MaddenDirector — — May 11, 2026 — —
Roland RottCEO — — Mar 4, 2026 — —

Board links: companies that share insiders with GEHC

Directors and executives who filed Form 4s for GEHC and another company in the last 12 months.

See the map →
  • GEGE Aerospace H. Lawrence Culp Jr. Director here · CEO, Chair at GE · latest filing Nov 12, 2026Catherine A. Lesjak Director here · Director at GE · latest filing May 11, 2026
  • DOCSDoximity Watkin Phoebe L. Yang Director here · Director at DOCS · latest filing Oct 2, 2026
  • HIIHuntington Ingalls Industries Frank R. Jimenez Gc & Corporate Secretary here · Director at HII · latest filing Oct 2, 2026
  • PHParker Hannifin Kevin Lobo Director here · Director at PH · latest filing May 26, 2026
  • SYKStryker Kevin Lobo Director here · CEO, Chair at SYK · latest filing May 26, 2026
  • XYLXylem William K. Grogan CFO here · CFO at XYL · latest filing Sep 16, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

GEHC stock: common questions

Are GE HealthCare insiders buying GEHC stock?

In the past 12 months, 8 insiders reported open-market purchases of GEHC worth $6.4M. The latest was Director Kevin Lobo bought $642K of GEHC at $64.18 — first open-market purchase in our records; raises the stake by 229%.

Are GE HealthCare insiders selling GEHC stock?

No. No GE HealthCare insider reported an open-market sale of GEHC in the past 12 months.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is GEHC's P/E ratio?

GEHC trades at about 16.6 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is GEHC's 52-week range?

Over the past year GEHC has traded between $59.45 and $88.03. It last closed at $81.77 on Nov 19, 2026.